Profile:

SAMI Pharmaceuticals (Pvt.) Ltd. Karachi-Pakistan is an established pharmaceutical manufacturer producing, since 1976, drugs of standard quality with full compliance of cGMP. With an annual turnover of US$ 221 million, SAMI is currently ranked as the 2nd largest pharmaceutical manufacturer of the Country (Source: IQVIA Qtr. 4, 2021)
Some of SAMI's brands enjoy leadership and dominance in important therapeutic areas like anti-infectives, rheumatology, narcotic analgesics, etc. SAMI follows aggressive ethical marketing through a large professional, experienced and motivated marketing team. SAMI enjoys technical collaboration and licensing arrangements with renowned European pharmaceutical manufacturers
SAMI has recently developed a state of the art fill-finish facility for Recombinant Proteins and Insulins to be produced in liquid and lyophilized forms, packed in ampoules, vials and PFS from respective bulk concentrates to be imported from competent sources. This facility has been developed based on the latest guidelines of international regulatory bodies